[HTML][HTML] The role of natural antioxidants in cisplatin-induced hepatotoxicity

N Abd Rashid, SAS Abd Halim, SL Teoh… - Biomedicine & …, 2021 - Elsevier
Cisplatin is a potent platinum-based anticancer drug approved by the Food Drug
Administration (FDA) in 1978. Despite its advantages against solid tumors, cisplatin confers …

The potential role of flavonoids in ameliorating diabetic cardiomyopathy via alleviation of cardiac oxidative stress, inflammation and apoptosis

FF Jubaidi, S Zainalabidin, IS Taib, ZA Hamid… - International journal of …, 2021 - mdpi.com
Diabetic cardiomyopathy is one of the major mortality risk factors among diabetic patients
worldwide. It has been established that most of the cardiac structural and functional …

[HTML][HTML] Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy

C Liu, Y Han, X Gu, M Li, Y Du, N Feng, J Li, S Zhang… - Redox Biology, 2021 - Elsevier
Diabetes disrupts mitochondrial function and often results in diabetic cardiomyopathy
(DCM). Paeonol is a bioactive compound that has been reported to have pharmacological …

Use of ferulic acid in the management of diabetes mellitus and its complications

X Li, J Wu, F Xu, C Chu, X Li, X Shi, W Zheng, Z Wang… - Molecules, 2022 - mdpi.com
Diabetes mellitus, a metabolic disease mainly characterized by hyperglycemia, is becoming
a serious social health problem worldwide with growing prevalence. Many natural …

Mitochondrial dysfunction and mitophagy in type 2 diabetes: pathophysiology and therapeutic targets

N Apostolova, T Vezza, J Muntane… - Antioxidants & Redox …, 2023 - liebertpub.com
Significance: Type 2 diabetes mellitus, which is related to oxidative stress and mitochondrial
dysfunction, is one of the most prevalent diseases in the world. In the past decade …

[HTML][HTML] Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments

F Zhi, Q Zhang, L Liu, X Chang, H Xu - Cell Stress and Chaperones, 2023 - Elsevier
Diabetic cardiomyopathy describes decreased myocardial function in diabetic patients in the
absence of other heart diseases such as myocardial ischemia and hypertension. Recent …

Breaking the vicious cycle: The interplay between loneliness, metabolic illness, and mental health

M Ahmed, I Cerda, M Maloof - Frontiers in Psychiatry, 2023 - frontiersin.org
Loneliness, or perceived social isolation, is a leading predictor of all-cause mortality and is
increasingly considered a public health epidemic afflicting significant portions of the general …

[HTML][HTML] Urolithin A prevents streptozotocin-induced diabetic cardiomyopathy in rats by activating SIRT1

G Albasher, S Alkahtani, LN Al-Harbi - Saudi journal of biological sciences, 2022 - Elsevier
This study examined the cardiac anti-cardiomyopathy (DC) protective effect of urolithin A in
streptozotocin (STZ)-treated rats and investigated if this protection involves activation of …

[PDF][PDF] Kaempferol protects against streptozotocin-induced diabetic cardiomyopathy in rats by a hypoglycemic effect and upregulating SIRT1.

AS Alshehri, AF El-Kott, SM Eleawa… - Journal of Physiology …, 2021 - jpp.krakow.pl
This study investigated if kaempferol could attenuate the oxidative, inflammatory, and fibrotic
damage of the left ventricles (LVs) in streptozotocin (STZ)-diabetic rats by modulating silent …

Hyperglycemic memory in diabetic cardiomyopathy

J Zhan, C Chen, DW Wang, H Li - Frontiers of Medicine, 2022 - Springer
Cardiovascular diseases account for approximately 80% of deaths among individuals with
diabetes mellitus, with diabetic cardiomyopathy as the major diabetic cardiovascular …